DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

60.92 -0.54 (-0.88%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $60.92 -0.88%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.24
Previous Close $61.46
Daily Range $60.87 - $61.55
52-Week Range $46.30 - $64.44
Market Cap $101.3B
P/E Ratio 51.22
Dividend (Yield) $1.48 (2.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,990,307
Average Daily Volume 5,818,009
Current FY EPS $1.65




Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary Rss Feed

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More

Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers

Abner Herrman's Top Three Holdings

Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176

Flexus Shows Other Immuno-Oncology Wannabes How It's Done

Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

The 3 Biggest Disappointments This Earnings Season

Some companies posted earnings (or outlooks) that missed the market's expectations. Here are three that really caught our attention.

Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog

Will Celldex Therapeutics (CLDX) Disappoint This Earnings? - Analyst Blog

See More BMY News...

BMY's Top Competitors

BMY $60.92 (-0.88%)
Current stock: BMY
JNJ $102.51 (-0.28%)
Current stock: JNJ
NVS $102.40 (-0.58%)
Current stock: NVS
RHHBY $34.13 (0.80%)
Current stock: RHHBY